276 related articles for article (PubMed ID: 21710544)
1. miR 488* inhibits androgen receptor expression in prostate carcinoma cells.
Sikand K; Slaibi JE; Singh R; Slane SD; Shukla GC
Int J Cancer; 2011 Aug; 129(4):810-9. PubMed ID: 21710544
[TBL] [Abstract][Full Text] [Related]
2. miR-103a-2-5p/miR-30c-1-3p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7.
Chen W; Yao G; Zhou K
J Cell Biochem; 2019 Aug; 120(8):14055-14064. PubMed ID: 30963631
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
4. MiR-133a-5p inhibits androgen receptor (AR)-induced proliferation in prostate cancer cells via targeting FUsed in Sarcoma (FUS) and AR.
Zheng L; Kang Y; Zhang L; Zou W
Cancer Biol Ther; 2020; 21(1):34-42. PubMed ID: 31736422
[TBL] [Abstract][Full Text] [Related]
5. Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.
Schmidt A; Meissner RS; Gentile MA; Chisamore MJ; Opas EE; Scafonas A; Cusick TE; Gambone C; Pennypacker B; Hodor P; Perkins JJ; Bai C; Ferraro D; Bettoun DJ; Wilkinson HA; Alves SE; Flores O; Ray WJ
J Steroid Biochem Mol Biol; 2014 Sep; 143():29-39. PubMed ID: 24565564
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-185 downregulates androgen receptor expression in the LNCaP prostate carcinoma cell line.
Liu C; Chen Z; Hu X; Wang L; Li C; Xue J; Zhang P; Chen W; Jiang A
Mol Med Rep; 2015 Jun; 11(6):4625-32. PubMed ID: 25673182
[TBL] [Abstract][Full Text] [Related]
7. Shortened isoforms of the androgen receptor are regulated by the cytoprotective heat-shock protein HSPB1 and the tumor-suppressive microRNA miR-1 in prostate cancer cells.
Stope MB; Bradl J; Peters S; Streitbörger A; Weiss M; Zimmermann U; Walther R; Lillig CH; Burchardt M
Anticancer Res; 2013 Nov; 33(11):4921-6. PubMed ID: 24222130
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of a novel androgen receptor transgene responsive to MicroRNA mediated post-transcriptional control exerted via 3'-untranslated region.
Ebron JS; Shukla GC
Prostate; 2016 Jun; 76(9):834-44. PubMed ID: 26988939
[TBL] [Abstract][Full Text] [Related]
9. miR-17-5p targets the p300/CBP-associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells.
Gong AY; Eischeid AN; Xiao J; Zhao J; Chen D; Wang ZY; Young CY; Chen XM
BMC Cancer; 2012 Oct; 12():492. PubMed ID: 23095762
[TBL] [Abstract][Full Text] [Related]
10. The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling.
Correa RG; Krajewska M; Ware CF; Gerlic M; Reed JC
Oncotarget; 2014 Mar; 5(6):1666-82. PubMed ID: 24681825
[TBL] [Abstract][Full Text] [Related]
11. Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening.
Kumar B; Khaleghzadegan S; Mears B; Hatano K; Kudrolli TA; Chowdhury WH; Yeater DB; Ewing CM; Luo J; Isaacs WB; Marchionni L; Lupold SE
Oncotarget; 2016 Nov; 7(45):72593-72607. PubMed ID: 27683042
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-99b-5p targets mTOR/AR axis, induces autophagy and inhibits prostate cancer cell proliferation.
Niture S; Tricoli L; Qi Q; Gadi S; Hayes K; Kumar D
Tumour Biol; 2022; 44(1):107-127. PubMed ID: 35811549
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells.
Shafi AA; Putluri V; Arnold JM; Tsouko E; Maity S; Roberts JM; Coarfa C; Frigo DE; Putluri N; Sreekumar A; Weigel NL
Oncotarget; 2015 Oct; 6(31):31997-2012. PubMed ID: 26378018
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel AR-targeted microRNAs mediating androgen signalling through critical pathways to regulate cell viability in prostate cancer.
Mo W; Zhang J; Li X; Meng D; Gao Y; Yang S; Wan X; Zhou C; Guo F; Huang Y; Amente S; Avvedimento EV; Xie Y; Li Y
PLoS One; 2013; 8(2):e56592. PubMed ID: 23451058
[TBL] [Abstract][Full Text] [Related]
15. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.
Östling P; Leivonen SK; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O
Cancer Res; 2011 Mar; 71(5):1956-67. PubMed ID: 21343391
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta.
Cao P; Deng Z; Wan M; Huang W; Cramer SD; Xu J; Lei M; Sui G
Mol Cancer; 2010 May; 9():108. PubMed ID: 20478051
[TBL] [Abstract][Full Text] [Related]
17. miR-141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein.
Xiao J; Gong AY; Eischeid AN; Chen D; Deng C; Young CY; Chen XM
Prostate; 2012 Oct; 72(14):1514-22. PubMed ID: 22314666
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians.
Shiina M; Hashimoto Y; Kato T; Yamamura S; Tanaka Y; Majid S; Saini S; Varahram S; Kulkarni P; Dasgupta P; Mitsui Y; Sumida M; Tabatabai L; Deng G; Kumar D; Dahiya R
Oncotarget; 2017 Jan; 8(5):8356-8368. PubMed ID: 28039468
[TBL] [Abstract][Full Text] [Related]
19. Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.
Chu M; Chang Y; Guo Y; Wang N; Cui J; Gao WQ
PLoS One; 2015; 10(4):e0116197. PubMed ID: 25860954
[TBL] [Abstract][Full Text] [Related]
20. miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer.
Pasqualini L; Bu H; Puhr M; Narisu N; Rainer J; Schlick B; Schäfer G; Angelova M; Trajanoski Z; Börno ST; Schweiger MR; Fuchsberger C; Klocker H
Mol Endocrinol; 2015 Jul; 29(7):1037-54. PubMed ID: 26052614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
